Showing 25,021 - 25,040 results of 224,509 for search '(( a ((laser decrease) OR (a decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 1.82s Refine Results
  1. 25021

    <i>microRNA-135a-5p</i> regulates <i>NOD-like receptor family pyrin domain containing 3</i> inflammasome-mediated hypertensive cardiac inflammation and fibrosis <i>via thioredoxin-... by Hao Chen (5190)

    Published 2022
    “…Moreover, over-expression of <i>miR-135a-5p</i> resulted in inhibition of inflammatory infiltration and almost eliminated cardiac fibrosis, as evidenced by decreased Collagen (COL)-I, COL-III, a-smooth muscle actin, <i>NLRP3</i>, tumor necrosis factor-α, and interleukin-6. …”
  2. 25022

    MiR-200a and miR-200b restrain inflammation by targeting ORMDL3 to regulate the ERK/MMP-9 pathway in asthma by Xiao-Jun Duan (9279077)

    Published 2020
    “…Therefore, elevating miR-200a and miR-200b and decreasing ORMDL3 might be potential strategies for inhibition of the asthma process.…”
  3. 25023

    Table_1_Identification and characterization of CLEC11A and its derived immune signature in gastric cancer.xlsx by Qing Zheng (659747)

    Published 2024
    “…Moreover, the flow cytometry assay showed that the knock-down of CLEC11A increased the infiltration of cytotoxic CD8+ T cells and helper CD4+ T into tumors while decreasing the percentage of M2 macrophages, MDSCs, and Tregs.…”
  4. 25024

    DataSheet_1_Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in... by Lei Dong (165252)

    Published 2022
    “…Background<p>The anti-phospholipase A2 receptor (PLA2R) antibody is a non-invasive diagnostic tool and prognosis predictor of idiopathic membranous nephropathy (IMN). …”
  5. 25025

    Data_Sheet_1_miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions.PDF by Na Li (6550)

    Published 2022
    “…Furthermore, EMT was induced, as shown by increased N-cadherin, vimentin, MMP2, and MMP9 and decreased E-cadherin in the placenta accreta spectrum group and in HTR-8/SVneo cells transfected with miR-193a-3p mimics or si-EFNB2. …”
  6. 25026

    Image_1_miR-193a-3p Mediates Placenta Accreta Spectrum Development by Targeting EFNB2 via Epithelial-Mesenchymal Transition Pathway Under Decidua Defect Conditions.TIFF by Na Li (6550)

    Published 2022
    “…Furthermore, EMT was induced, as shown by increased N-cadherin, vimentin, MMP2, and MMP9 and decreased E-cadherin in the placenta accreta spectrum group and in HTR-8/SVneo cells transfected with miR-193a-3p mimics or si-EFNB2. …”
  7. 25027

    Data_Sheet_1_Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits.pdf by Pragnya Das (8692077)

    Published 2020
    “…Background<p>Invasive mechanical ventilation (IMV) has become one of the mainstays of therapy in NICUs worldwide, as a result of which premature babies with extremely low birth weight have been able to survive. …”
  8. 25028

    X-ray Single-Crystal Structure and Magnetic Properties of Fe[CH<sub>3</sub>PO<sub>3</sub>)]·H<sub>2</sub>O:  A Layered Weak Ferromagnet by Carlo Bellitto (2069203)

    Published 2002
    “…Below 100 K, the magnetic moment of Fe[CH<sub>3</sub>PO<sub>3</sub>]·H<sub>2</sub>O rises rapidly to a maximum at <i>T</i><sub>max</sub> ≅ 24 K, and then it decreases again. …”
  9. 25029

    Image_2_Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits.TIF by Pragnya Das (8692077)

    Published 2020
    “…Background<p>Invasive mechanical ventilation (IMV) has become one of the mainstays of therapy in NICUs worldwide, as a result of which premature babies with extremely low birth weight have been able to survive. …”
  10. 25030

    DataSheet1_Calmodulin mutations affecting Gly114 impair binding to the NaV1.5 IQ-domain.docx by Malene Brohus (840080)

    Published 2023
    “…The disease mechanisms have been attributed to dysregulation of RyR2, for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) and/or Ca<sub>V</sub>1.2, for Long-QT Syndrome (LQTS). Recently, a novel CALM2 variant, G114R, was identified in a mother and two of her four children, all of whom died suddenly while asleep at a young age. …”
  11. 25031

    Image_1_Small Molecule Inhibitor Adjuvant Surfactant Therapy Attenuates Ventilator- and Hyperoxia-Induced Lung Injury in Preterm Rabbits.TIF by Pragnya Das (8692077)

    Published 2020
    “…Background<p>Invasive mechanical ventilation (IMV) has become one of the mainstays of therapy in NICUs worldwide, as a result of which premature babies with extremely low birth weight have been able to survive. …”
  12. 25032

    Image_4_KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.tif by Shuhua Zhang (826829)

    Published 2022
    “…Through decreasing nuclear NSD1 level, KB-68A7.1 reduced di-methylation of histone H3 at lysine 36 (H3K36me2) and increased tri-methylation of histone H3 at lysine 27 (H3K27me3) at the promoter of WNT10B, a target of NSD1. …”
  13. 25033

    DataSheet_1_KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.zip by Shuhua Zhang (826829)

    Published 2022
    “…Through decreasing nuclear NSD1 level, KB-68A7.1 reduced di-methylation of histone H3 at lysine 36 (H3K36me2) and increased tri-methylation of histone H3 at lysine 27 (H3K27me3) at the promoter of WNT10B, a target of NSD1. …”
  14. 25034

    Image_3_KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.tif by Shuhua Zhang (826829)

    Published 2022
    “…Through decreasing nuclear NSD1 level, KB-68A7.1 reduced di-methylation of histone H3 at lysine 36 (H3K36me2) and increased tri-methylation of histone H3 at lysine 27 (H3K27me3) at the promoter of WNT10B, a target of NSD1. …”
  15. 25035

    Image_1_KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.tif by Shuhua Zhang (826829)

    Published 2022
    “…Through decreasing nuclear NSD1 level, KB-68A7.1 reduced di-methylation of histone H3 at lysine 36 (H3K36me2) and increased tri-methylation of histone H3 at lysine 27 (H3K27me3) at the promoter of WNT10B, a target of NSD1. …”
  16. 25036

    DataSheet_1_Loss of Lipocalin 10 Exacerbates Diabetes-Induced Cardiomyopathy via Disruption of Nr4a1-Mediated Anti-Inflammatory Response in Macrophages.docx by Qianqian Li (386223)

    Published 2022
    “…Mechanistically, RNA-sequencing analysis showed that Nr4a1, a nuclear receptor known to have potent anti-inflammatory effects, is involved in Lcn10-mediated macrophage activation. …”
  17. 25037

    DataSheet_2_Loss of Lipocalin 10 Exacerbates Diabetes-Induced Cardiomyopathy via Disruption of Nr4a1-Mediated Anti-Inflammatory Response in Macrophages.xlsx by Qianqian Li (386223)

    Published 2022
    “…Mechanistically, RNA-sequencing analysis showed that Nr4a1, a nuclear receptor known to have potent anti-inflammatory effects, is involved in Lcn10-mediated macrophage activation. …”
  18. 25038

    Image_2_KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.tif by Shuhua Zhang (826829)

    Published 2022
    “…Through decreasing nuclear NSD1 level, KB-68A7.1 reduced di-methylation of histone H3 at lysine 36 (H3K36me2) and increased tri-methylation of histone H3 at lysine 27 (H3K27me3) at the promoter of WNT10B, a target of NSD1. …”
  19. 25039
  20. 25040

    Treating sleep disturbances in refugees and asylum seekers: results from a randomized controlled pilot trial evaluating the STARS group intervention by Britta Dumser (20698169)

    Published 2025
    “…However, there was no significant interaction with condition at post-treatment for the primary outcome (<i>d</i> = 0.29) and most secondary outcomes; the only exceptions were increased coping with nightmares, decreased daytime sleep, and time in bed.</p> <p><b>Conclusions:</b> STARS appears feasible for treating sleep disturbances in traumatized refugees in a routine clinical setting, showing moderate to large within-group effects. …”